Home Cart Sign in  
Chemical Structure| 5957-80-2 Chemical Structure| 5957-80-2

Structure of Carnosol
CAS No.: 5957-80-2

Chemical Structure| 5957-80-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Carnosol, a natural product isolated and purified from the herbs of Rosmarinus officinalis L., enhances the sensitivity of chemoresistant cancer cells to chemotherapeutic agents. Carnosol may as an agonist of TRPA1 with an EC50 value of 12.46 µM.

Synonyms: NSC 39143

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Carnosol

CAS No. :5957-80-2
Formula : C20H26O4
M.W : 330.42
SMILES Code : O=C1O[C@]2([H])C3=C(C(O)=C(O)C(C(C)C)=C3)[C@@]41CCCC(C)(C)[C@]4([H])C2
Synonyms :
NSC 39143
MDL No. :MFCD02752467
InChI Key :XUSYGBPHQBWGAD-PJSUUKDQSA-N
Pubchem ID :442009

Safety of Carnosol

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Carnosol

MAPK
PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human monocytes 3-30 μM 10 min Inhibition of COX and mPGES-1 product formation, particularly PGE2 and PGE1. Br J Pharmacol. 2017 Jun;174(11):1497-1508
Human neutrophils 3-30 μM 10 min Inhibition of 5-LO and 12/15-LO product formation, particularly LTB4, 5-HETE, 5-oxo-ETE, etc. Br J Pharmacol. 2017 Jun;174(11):1497-1508
N2a58 cells 16.53 μM 48 h To evaluate the antioxidant effect of Carnosol. Results showed that Carnosol significantly reduced ROS production. Antioxidants (Basel). 2022 Apr 6;11(4):726.
N2a22L cells 12.85 μM 48 h To evaluate the antioxidant and anti-prion effects of Carnosol. Results showed that Carnosol significantly reduced ROS production and decreased PrPSc accumulation. Antioxidants (Basel). 2022 Apr 6;11(4):726.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Mouse models of NLRP3 inflammasome-mediated diseases, including endotoxemia and nonalcoholic steatohepatitis (NASH) Intraperitoneal administration 120 mg/kg Once daily for two weeks Carnosol has remarkable therapeutic effects in mouse models of NLRP3 inflammasome-mediated diseases, including endotoxemia and nonalcoholic steatohepatitis (NASH). Our data also suggest that intraperitoneal administration of carnosol (120 mg/kg) once daily for two weeks is well tolerated in mice. Cell Death Dis. 2020 Apr 20;11(4):252
HR1 mice UVB-induced skin inflammation model Topical application 0.05 μg/cm2 Three times a week for four weeks To investigate the protective effect of Carnosol on UVB-induced skin inflammation. Results showed that Carnosol significantly inhibited UVB-induced erythema, epidermal thickening, and inflammatory responses, reduced serum levels of IgE and IL-1β, and suppressed the expression of inflammatory marker proteins (iNOS and COX-2). Additionally, Carnosol decreased the activation of STAT3. Arch Pharm Res. 2019 Mar;42(3):274-283
C57BL/6J mice Unilateral ureteral obstruction (UUO) model Intraperitoneal injection 50 mg/kg Once daily for 8 consecutive days To investigate the protective effects of Carnosol on UUO-induced renal injury and fibrosis. Results showed that Carnosol improved renal function, attenuated tubular injury and interstitial fibrosis, suppressed oxidative injury and ER stress, inhibited apoptotic and necroptotic cell death, and alleviated inflammatory responses. Antioxidants (Basel). 2022 Nov 26;11(12):2341

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.03mL

0.61mL

0.30mL

15.13mL

3.03mL

1.51mL

30.26mL

6.05mL

3.03mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories